317 results on '"Magdolen V"'
Search Results
2. miR-27a, miR-206 und miR-214 als prädiktive Marker beim tripel-negativen Mammakarzinom
3. Zellbiologische Grundlagen
4. Urokinasetyp-Plasminogenaktivator (uPA), sein Inhibitor PAI-1 und sein Rezeptor (CD87) sind an Tumorinvasion und Metastasierung solider maligner Tumoren beteiligt
5. Circulating biomarker tissue kallikrein-related peptidase KLK5 impacts ovarian cancer patients’ survival
6. UVB-Strahlung induziert Plasminogenaktivator vom Urokinasetyp (uPA) und uPA-Rezeptor in der Keratinozytenlinie A431 — Bedeutung für die Photoprovozierbarkeit von Pemphigus vulgaris
7. Purification of Profilin from Saccharomyces cerevisiae and Analysis of Profilin-Deficient Cells
8. Efficient factor VIII affinity purification using a small synthetic ligand
9. Die Kallikrein-ähnliche Peptidase KLK7 als neue Zielstruktur zur Verbesserung der Immuntherapie im Ovarialkarzinom
10. Expression of the urokinase-type plasminogen activator receptor in human articular chondrocytes: association with caveolin and β1-integrin
11. Characterization of breast cancer cell lines overexpressing the urokinase receptor splice variant uPAR-del4/5 or the GTP binding protein rab31: O5B-6
12. The human fibrinolytic system is a target for proteases secreted by the pathogenic bacterium Pseudomonas aeruginosa: O4B-3
13. Interplay of human kallikrein-related peptidases (KLKs) with the tumor-associated urokinase/plasmin system: O7–03
14. Urokinase receptor splice variant uPAR-del4/5-associated gene expression in breast cancer: prognostic relevance of rab31 and dermatopontin mRNA expression: O1–01
15. Validation of immunolocalization of the urokinase receptor expression in ductal carcinoma in situ of the breast: comparison with detection by non-isotopic in-situ hybridization
16. Kallikrein‐related peptidases are activators of the CC chemokine CCL14
17. EPITOPE-MAPPED MONOCLONAL ANTIBODIES DIRECTED TO THE HUMAN UROKINASE RECEPTOR (uPAR, CD87): MC-2-02
18. Kallikrein-related peptidase 8 leupeptin inhibitor complex
19. Kallikrein-related peptidase 8 calcium complex
20. Assessment of kallikrein-related peptidase 5 (KLK5) protein expression in tumor tissue of advanced ovarian cancer patients by immunohistochemistry and ELISA: correlation with clinical outcome
21. Kallikrein-related peptidase 10
22. Kallikrein-related peptidase 10 complex with Zn2+
23. Quantitative reverse transcription-PCR assay for detection of mRNA encoding full-length human tissue kallikrein 7: prognostic relevance of KLK7 mRNA expression in breast cancer
24. Secretome and degradome profiling shows that Kallikrein-related peptidases 4, 5, 6, and 7 induce TGF\u03b2-1 signaling in ovarian cancer cells
25. Development of urokinase-derived peptide analogues as potential therapeutic agents to block tumor invasion and metastasis
26. Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies
27. Highlight: The 4th international symposium on Kallikreins and Kallikrein-Related Peptidases
28. Human kallikrein-related peptidase 2 in complex with PPACK
29. Human kallikrein-related peptidase 2 in complex with benzamidine
30. Fibrinolytics, enzyme inhibitors, and cancer survival
31. Suppression of rat breast cancer metastasis and reduction of primary tumour growth by the small synthetic urokinase inhibitor WX-UKI
32. Prognostische Rolle des Metastasierungssuppressors KAI1 (CD82) beim Ovarialkarzinom
33. 103: The tumour–stroma niche of ovarian cancer in 3D
34. 294 Prognostic impact of urokinase-type plasminogen activator system components in patients with clear cell renal cell carcinoma
35. C192 ANALYSIS OF COMPONENTS OF THE UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) SYSTEM IN TUMOR TISSUE AND SERUM OF PROSTATE CANCER PATIENTS
36. 113 Unravelling the Tumour-stroma Microenvironment of Late Stage Ovarian Cancer
37. Circulating biomarker tissue kallikrein-related peptidase KLK5 impacts ovarian cancer patients' survival.
38. Co-detection of members of the urokinase plasminogen activator system in tumour tissue and serum correlates with a poor prognosis for soft-tissue sarcoma patients
39. Protein kinase Cδ expression in breast cancer as measured by real-time PCR, western blotting and ELISA
40. Crystal Structure of Human Kallikrein 7 in Complex with Suc-Ala-Ala-Pro-Phe-chloromethylketone
41. High resolution structure of Human Kallikrein 7 in Complex with Suc-Ala-Ala-Pro-Phe-chloromethylketone
42. Crystal Structure of Human Kallikrein 7 in Complex with Suc-Ala-Ala-Pro-Phe-chloromethylketone and Copper
43. Crystal Structure of Human Kallikrein 7 in Complex with Ala-Ala-Phe-chloromethylketone
44. CLINICAL RELEVANCE AND TUMOR BIOLOGICAL ROLE OF THE UROKINASE RECEPTOR MRNA SPLICE VARIANT UPAR-DEL4/5 IN BREAST CANCER
45. Transgenic mice expressing a surfactant protein B–urokinase fusion protein in the distal respiratory epithelium are protected against acute lung injury and postinflammatory fibrosis
46. ID: 119 Effects of overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 on the malignant phenotype of ovarian cancer cells
47. ID: 117 Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and PAI-1 in primary ovarian carcinoma
48. Tumorassoziierte Prognosefaktoren der Plasminogenaktivator-Familie
49. Inhibition of Intraperitoneal Tumor Growth of Human Ovarian Cancer Cells by Bi- and Trifunctional Inhibitors of Tumor-Associated Proteolytic Systems
50. Molecular and Functional Interdependence of the Urokinase-Type Plasminogen Activator System with Integrins
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.